CELC
NASDAQ
$87.99
Celcuity Inc (CELC)
Celcuity Inc., a clinical-stage biotechnology company, discovers cancer subtypes and therapeutic options for cancer patients in the United States. The company is headquartered in Minneapolis, Minnesota.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $163.45 (+85.76%)
Market Cap
$4.42B
EPS 5Y CAGR
+36.83%
FCF 5Y CAGR
+86.86%
Free Cash Flow Yield
-3.91%
Price Chart
Valuation
Market Cap$4.42B
P/B101.18
Profitability
EBITDA-$186M
EPS-$4.33
Financial Health
Debt-to-Equity257.6%
Free Cash Flow Yield-3.91%
Growth & Risk
EPS 5Y CAGR+36.83%
FCF 5Y CAGR+86.86%
Beta (5Y)1.07
Sharpe Ratio1.53